8-K/AThe WireRoutine
Company Update
Filed Nov 16, 2022 · 3y ago · Accession 0001193125-22-285963
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 8-K/A
- Filing date
- Nov 16, 2022
- Report date
- Nov 10, 2022
- Document
- d408792d8ka.htm
- Size
- 270 KB